Sonofusion

Company Overview

Snapshot

Founded in November 2025, Sonofusion operates with 1–10 employees. The company is currently in the Pre-Funding stage, developing its non-invasive ultrasound surgery platform.

Business overview

Sonofusion is a medical technology company developing a platform for non-invasive ultrasound surgery. Its proprietary system integrates histotripsy and thermal ablation to accurately target and eliminate tumors and other pathologies without requiring incisions or ionizing radiation. The company aims to enhance clinical outcomes, reduce recovery times, and broaden access to advanced therapies in both hospital and outpatient environments, with a primary focus on oncology and other conditions where focused ultrasound can serve as an alternative or complement to traditional surgical and radiotherapy procedures.

Company Intelligence Q&A

What is Sonofusion's core technology?

Sonofusion develops a medical technology platform for non-invasive ultrasound surgery, combining histotripsy and thermal ablation to precisely target and destroy tumors and other pathologies.

When was Sonofusion founded?

Sonofusion was founded in November 2025.

What markets does Sonofusion target?

Sonofusion targets geomarkets including Middle Africa, Europe, North America, and Asia, focusing on oncology and other indications where focused ultrasound can replace or complement conventional surgical and radiotherapy procedures.

What is Sonofusion's primary business model?

Sonofusion operates with a B2B business model.

What is Sonofusion's product, SonoFusion?

Sonofusion's product, SonoFusion, is currently in the Clinical Trial stage, indicating it is undergoing testing in human subjects to evaluate its safety and efficacy.